1 résultat(s) recherche sur le mot-clé 'متلازمة الفم الحارق'    

BURNING MOUTH SYNDROME / Naoufal ANOUK 

Public ISBD Titre : BURNING MOUTH SYNDROME Type de document : thèse Auteurs : Naoufal ANOUK, Auteur Année de publication : 2022 Langues : Anglais (eng) Mots-clés : Burning mouth syndrome  Neuropathic pain  Xerostomia  PBMS  SBMS  Syndrome de la bouche brûlante  Douleur neuropathique  Xérostomie  Stomatodynie primaire  Stomatodynie secondaire  متلازمة الفم الحارق  ألم الاعتلال العصبي  جفاف الفم  حرق الفم الأولي  حرق الفم الثانوي Résumé : Burning mouth syndrome (BMS) or stomatodynia is represented by the existence of burning feeling or sensation of the oral mucosa in the absence of clinically evident mucosal changes. It appears more frequently in middle-aged and elderly women and usually alters lips, the lateral borders, tip of the tongue, and both soft and hard palate. Along with the burning feeling, patients that suffer from BMS may also report constant oral pain, xerostomia, and dysgeusia. BMS can be divided into two clinical forms: primary and secondary burning mouth syndrome (PBMS and SBMS). The PBMS or idiopathic, in which no organic local/systemic causes can be established and a neuropathological cause is probable. The diagnosis of PBMS is based principally on elimination of etiological factors. The SBMS is caused by local, systemic, and/or psychological factors; therefore, its diagnosis is based on detecting the precise causative factor. When local, systemic or psychological factors are present, treatment or elimination of these causes generally results in a clinical improvement of symptoms. Vitamin, zinc, or hormone replacement therapy (HRT) has been noted to be useful for decreasing the burning sensation in some BMS patients with lack of the corresponding factor. If patients still present the symptoms after the elimination of potential causes, drug treatment must be initiated. Previous clinical trials found that drug treatment (with clonazepam, α-lipoic acid (ALA), antidepressants, and capsaicin) can relieve the pain, as well as psychotherapy who can also help eliminate the BMS symptoms. Numéro (Thèse ou Mémoire) : M1532022 Président : Fouad BENARIBA Directeur : Noureddine ERRAMI Juge : Nawfal FEJJAL Juge : Bouchaib HEMMAOUI Juge : Lahcen KHALFI BURNING MOUTH SYNDROME [thèse] / Naoufal ANOUK, Auteur . - 2022. Langues : Anglais (eng) Mots-clés : Burning mouth syndrome  Neuropathic pain  Xerostomia  PBMS  SBMS  Syndrome de la bouche brûlante  Douleur neuropathique  Xérostomie  Stomatodynie primaire  Stomatodynie secondaire  متلازمة الفم الحارق  ألم الاعتلال العصبي  جفاف الفم  حرق الفم الأولي  حرق الفم الثانوي Résumé : Burning mouth syndrome (BMS) or stomatodynia is represented by the existence of burning feeling or sensation of the oral mucosa in the absence of clinically evident mucosal changes. It appears more frequently in middle-aged and elderly women and usually alters lips, the lateral borders, tip of the tongue, and both soft and hard palate. Along with the burning feeling, patients that suffer from BMS may also report constant oral pain, xerostomia, and dysgeusia. BMS can be divided into two clinical forms: primary and secondary burning mouth syndrome (PBMS and SBMS). The PBMS or idiopathic, in which no organic local/systemic causes can be established and a neuropathological cause is probable. The diagnosis of PBMS is based principally on elimination of etiological factors. The SBMS is caused by local, systemic, and/or psychological factors; therefore, its diagnosis is based on detecting the precise causative factor. When local, systemic or psychological factors are present, treatment or elimination of these causes generally results in a clinical improvement of symptoms. Vitamin, zinc, or hormone replacement therapy (HRT) has been noted to be useful for decreasing the burning sensation in some BMS patients with lack of the corresponding factor. If patients still present the symptoms after the elimination of potential causes, drug treatment must be initiated. Previous clinical trials found that drug treatment (with clonazepam, α-lipoic acid (ALA), antidepressants, and capsaicin) can relieve the pain, as well as psychotherapy who can also help eliminate the BMS symptoms. Numéro (Thèse ou Mémoire) : M1532022 Président : Fouad BENARIBA Directeur : Noureddine ERRAMI Juge : Nawfal FEJJAL Juge : Bouchaib HEMMAOUI Juge : Lahcen KHALFI

Réservation

Réserver ce document

Exemplaires

Code barre	Cote	Support	Localisation	Section	Disponibilité
M1532022	WA	Thèse imprimé	Unité des Thèses et Mémoires	ThèsesMed2022	Disponible

Documents numériques

M1532022 URL